ArticleCancers2026

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Eline G M Steenhuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.